Markets Rebound After Tuesday’s Sell-off, An Exclusive With Exxon Mobil's Chairman & CEO, Salesforce Slumps and Names a Co-CEO, and An FDA Panel Endorses Merck's COVID-19 Pill.
On the first trading day of December, Carl Quintanilla, Jim Cramer and David Faber discussed the rebound in stocks after Tuesday's sell-off was sparked by COVID and inflation fears. In a CNBC Exclusive, David Faber interviewed Exxon Mobil Chairman & CEO Darren Woods about the company's capital spending plan. The energy giant says it expects to double earnings and cash flow by 2027 from 2019's levels -- while also reducing emissions. The anchors reacted to shares of Salesforce declining sharply as guidance overshadowed better-than-expected quarterly results. The company also promoted Bret Taylor to the role of Co-CEO alongside Marc Benioff -- this after Taylor was named chairman of Twitter earlier in the week. Also in focus: Merck's oral COVID-19 treatment was narrowly endorsed by an FDA panel, EV stocks join the rally, plus Phil LeBeau's interview with the CEO of GE Aviation.